Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2018 at "Current Pharmaceutical Biotechnology"
DOI: 10.2174/1389201019666180611093428
Abstract: Background: Oligonucleotide drug development has revolutionised the drug discovery field. Within this field, ‘small’ or ‘short’ activating RNAs (saRNA) are a more recently discovered category of short double-stranded RNA with clinical potential. saRNAs promote transcription… read more here.
Keywords: drug; development mtl; mtl cebpa; carcinoma ... See more keywords